MedTrace Logo

Evaluating of Role of Myeloperoxidase in Prediction of Outcomes of Cardiac Surgery Procedures.

NCT03786965 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2021-11-16

No results posted yet for this study

Summary

The main objection is to investigate molecular biology of myocardial damage during cardiac surgery procedures.

Conditions

  • Cardiac Procedure Complication
  • Ischemic Heart Disease
  • Valve Heart Disease
  • Defect Septal

Interventions

OTHER

On-pump CABG

On-pump CABG

OTHER

Off-pump CABG

Off-pump CABG

OTHER

Pump-assisted CABG

Pump-assisted CABG

OTHER

Valve Repair Procedure without CABG.

Valve Repair Procedure without CABG (open heart procedure).

OTHER

Valve Repair Procedure with CABG.

Valve Repair Procedure with CABG (open heart procedure).

Sponsors & Collaborators

  • St. Petersburg State Pavlov Medical University

    lead OTHER

Principal Investigators

  • Alexander Nemkov, PhD · First Saint-Petersburg Medical University

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-20
Primary Completion
2025-07-20
Completion
2025-12-20

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03786965 on ClinicalTrials.gov